Associations of polymorphisms on vemurafenib-associated toxicities in patients with melanoma
Latest Information Update: 12 Aug 2020
At a glance
- Drugs Cobimetinib (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 12 Aug 2020 New trial record